Cornerstone Wealth Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Cornerstone Wealth Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,000	Closed	-$260K	–	357
2016 Q4	$260K	Hold	21,000	–	–	0.08%	229
2016 Q3	$281K	Buy	+21,000	New	+$211K	0.1%	205

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Cornerstone Wealth Management's ARIA Position: Q1 2017 in Review

Cornerstone Wealth Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 21,000 shares — an estimated $260K sold.

Cornerstone Wealth Management first reported a position in ARIA in Q3 2016 and held it in 2 quarters. The position peaked at $281K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Cornerstone Wealth Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Cornerstone Wealth Management sold 21,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $260K.
Cornerstone Wealth Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2016 and held it in 2 quarters.
Cornerstone Wealth Management's Ariad Pharmaceuticals Inc position peaked at $281K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Cornerstone Wealth Management's 13F filing for Q1 2017, filed 12 May 2017.